| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Heather E Soder, Amber M Berumen, Kira E Gomez, Charles E Green, Robert Suchting, Margaret C Wardle, Jessica Vincent, Antonio L Teixeira, Joy M Schmitz, Scott D Lan. Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 18. issue 1. 2020-09-28. PMID:31958903. |
the present study focused on cocaine use disorder (cud) to examine if cocaine adds further inflammatory burden among older adults, by comparing nlr values between older adults with cud and a non-cocaine using, aged-matched, nationally representative sample. |
2020-09-28 |
2023-08-13 |
Not clear |
| Michelle A Land, Divya Ramesh, Aaron L Miller, Richard B Pyles, Kathryn A Cunningham, F Gerard Moeller, Noelle C Anastasi. Methylation Patterns of the Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32587535. |
methylation patterns of the relapse during abstinence in cocaine use disorder (cud) is often hastened by high impulsivity (predisposition toward rapid unplanned reactions to stimuli without regard to negative consequences) and high cue reactivity (e.g., attentional bias towards drug reward stimuli). |
2020-09-28 |
2023-08-13 |
Not clear |
| Jin H Yoon, Robert Suchting, Sarah A McKay, Guadalupe G San Miguel, Anka A Vujanovic, Angela L Stotts, Scott D Lane, Jessica N Vincent, Michael F Weaver, Austin Lin, Joy M Schmit. Baseline cocaine demand predicts contingency management treatment outcomes for cocaine-use disorder. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. vol 34. issue 1. 2020-09-09. PMID:31233323. |
cocaine use disorder (cud) is a significant public health issue. |
2020-09-09 |
2023-08-13 |
human |
| Eduardo R Butelman, Carina Y Chen, Rachel A Conybeare, Kate G Brown, Rebecca S Fry, Rachel Kimani, Joel Correa da Rosa, Jürg Ott, Mary Jeanne Kree. Are trait impulsivity and exposure to cannabis or alcohol associated with the age of trajectory of cocaine use? A gender-specific dimensional analysis in humans with cocaine dependence diagnosis. Experimental and clinical psychopharmacology. vol 28. issue 3. 2020-09-08. PMID:31424236. |
cocaine use disorders (cud) cause major morbidity and optimized prevention efforts are critical. |
2020-09-08 |
2023-08-13 |
human |
| Eduardo R Butelman, Carina Y Chen, Rachel A Conybeare, Kate G Brown, Rebecca S Fry, Rachel Kimani, Joel Correa da Rosa, Jürg Ott, Mary Jeanne Kree. Are trait impulsivity and exposure to cannabis or alcohol associated with the age of trajectory of cocaine use? A gender-specific dimensional analysis in humans with cocaine dependence diagnosis. Experimental and clinical psychopharmacology. vol 28. issue 3. 2020-09-08. PMID:31424236. |
it is unclear if trait impulsivity and exposure to cannabis or alcohol are associated with age trajectory of cocaine use (e.g., age of onset of heaviest use, or time of escalation), or with vulnerability to develop a cud. |
2020-09-08 |
2023-08-13 |
human |
| André Q C Miguel, Ayana Jordan, Brian D Kiluk, Charla Nich, Theresa A Babuscio, Jair J Mari, Kathleen M Carrol. Sociodemographic and clinical outcome differences among individuals seeking treatment for cocaine use disorders. The intersection of gender and race. Journal of substance abuse treatment. vol 106. 2020-09-04. PMID:31540613. |
most published treatment trials for cocaine use disorders (cud) have been conducted with samples composed predominantly of white men and underrepresent women and racial/ethnic minorities. |
2020-09-04 |
2023-08-13 |
Not clear |
| Elise E DeVito, Kathleen M Carroll, Theresa Babuscio, Charla Nich, Mehmet Sofuogl. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal of substance abuse treatment. vol 107. 2020-08-31. PMID:31757262. |
no pharmacotherapies are approved for the treatment of cocaine use disorder (cud). |
2020-08-31 |
2023-08-13 |
Not clear |
| Elise E DeVito, Kathleen M Carroll, Theresa Babuscio, Charla Nich, Mehmet Sofuogl. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal of substance abuse treatment. vol 107. 2020-08-31. PMID:31757262. |
galantamine, a cholinesterase inhibitor, has shown initial promise for cocaine use reduction in methadone-maintained individuals with cud and cognitive improvement in abstinent individuals with past cud. |
2020-08-31 |
2023-08-13 |
Not clear |
| Elise E DeVito, Kathleen M Carroll, Theresa Babuscio, Charla Nich, Mehmet Sofuogl. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal of substance abuse treatment. vol 107. 2020-08-31. PMID:31757262. |
the goal of this 13-week, double-blind, placebo-controlled, randomized controlled trial was to test the efficacy of galantamine (8 mg or 16 mg/day; extended release (er)) for reducing cocaine use and improving cognitive function in individuals with cocaine use disorder (cud). |
2020-08-31 |
2023-08-13 |
Not clear |
| Elise E DeVito, Kathleen M Carroll, Theresa Babuscio, Charla Nich, Mehmet Sofuogl. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal of substance abuse treatment. vol 107. 2020-08-31. PMID:31757262. |
these findings did not provide support for the efficacy of galantamine as a treatment for cocaine use in this sample of individuals with cud. |
2020-08-31 |
2023-08-13 |
Not clear |
| Thiago Wendt Viola, Jaqueline Bohrer Schuch, Diego Luiz Rovaris, Rafael Genovese, Lucca Tondo, Breno Sanvicente-Vieira, Aline Zaparte, Renata Basso Cupertino, Bruna Santos da Silva, Claiton Henrique Dotto Bau, Rodrigo Grassi-Oliveir. Association between cognitive performance and SYT1-rs2251214 among women with cocaine use disorder. Journal of neural transmission (Vienna, Austria : 1996). vol 126. issue 12. 2020-08-17. PMID:31562556. |
the snp rs2251214 of the syt1 gene was recently associated with externalizing phenotypes, including adhd and cocaine use disorder (cud). |
2020-08-17 |
2023-08-13 |
Not clear |
| Benjamin W Van Tassell, Peter Westman, Cory Trankle, Sade Johns, Dinesh Kadariya, Leo Buckley, Salvatore Carbone, Antonio Abbate, Frederick Gerard Moelle. Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder. Journal of cardiovascular pharmacology. vol 74. issue 6. 2020-07-27. PMID:31809403. |
cocaine use disorder (cud) is a common problem in the united states and worldwide. |
2020-07-27 |
2023-08-13 |
human |
| Benjamin W Van Tassell, Peter Westman, Cory Trankle, Sade Johns, Dinesh Kadariya, Leo Buckley, Salvatore Carbone, Antonio Abbate, Frederick Gerard Moelle. Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder. Journal of cardiovascular pharmacology. vol 74. issue 6. 2020-07-27. PMID:31809403. |
subjects with chronic cud represent a special population that has experienced long-term cocaine exposure, often without showing signs of cardiovascular disease. |
2020-07-27 |
2023-08-13 |
human |
| Benjamin W Van Tassell, Peter Westman, Cory Trankle, Sade Johns, Dinesh Kadariya, Leo Buckley, Salvatore Carbone, Antonio Abbate, Frederick Gerard Moelle. Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder. Journal of cardiovascular pharmacology. vol 74. issue 6. 2020-07-27. PMID:31809403. |
we herein present prospectively collected data on the acute hemodynamic effects of intravenous cocaine in a cohort of nontreatment-seeking individuals with cud without cardiovascular disease. |
2020-07-27 |
2023-08-13 |
human |
| Corey R Roos, Charla Nich, Chung Jung Mun, Theresa A Babuscio, Justin Mendonca, André Q C Miguel, Elise E DeVito, Sarah W Yip, Katie Witkiewitz, Kathleen M Carroll, Brian D Kilu. Clinical validation of reduction in cocaine frequency level as an endpoint in clinical trials for cocaine use disorder. Drug and alcohol dependence. vol 205. 2020-07-06. PMID:31677490. |
we conducted a clinical validation of reduction in cocaine frequency level as a non-abstinence endpoint in rcts for cocaine use disorder (cud). |
2020-07-06 |
2023-08-13 |
Not clear |
| Thiago Wendt Viola, Bernardo Aguzzoli Heberle, Aline Zaparte, Breno Sanvicente-Vieira, Leonardo Mendes Wainer, Gabriel Rodrigo Fries, Consuelo Walss-Bass, Rodrigo Grassi-Oliveir. Peripheral blood microRNA levels in females with cocaine use disorder. Journal of psychiatric research. vol 114. 2020-06-25. PMID:31026664. |
based on translational and clinical findings, we compared the expression levels of microrna-124 (mir-124), microrna-181 (mir-181), and microrna-212 (mir-212) between a group of females with cocaine use disorder (cud; n = 30) and a group of healthy female controls (hc; n = 20). |
2020-06-25 |
2023-08-13 |
Not clear |
| Theresa M Winhusen, Jeff Theobald, Daniel F Lewi. Substance use outcomes in cocaine-dependent tobacco smokers: A mediation analysis exploring the role of sleep disturbance, craving, anxiety, and depression. Journal of substance abuse treatment. vol 96. 2020-05-28. PMID:30466549. |
sleep disturbance may play a role in cocaine use outcomes and, hence, may be a potential therapeutic target for cocaine use disorder (cud). |
2020-05-28 |
2023-08-13 |
Not clear |
| Kyle M Kampma. The treatment of cocaine use disorder. Science advances. vol 5. issue 10. 2020-05-21. PMID:31663022. |
psychosocial treatments remain the treatments of choice for cocaine use disorder (cud), with standard approaches including contingency management and cognitive behavioral therapy. |
2020-05-21 |
2023-08-13 |
Not clear |
| Jonathan Buchholz, Andrew J Saxo. Medications to treat cocaine use disorders: current options. Current opinion in psychiatry. vol 32. issue 4. 2020-05-20. PMID:31008728. |
despite these concerns, there are no food and drug administration-approved medications for the treatment of cocaine use disorder (cud). |
2020-05-20 |
2023-08-13 |
Not clear |
| Christina Gobin, Marek Schwend. The cognitive cost of reducing relapse to cocaine-seeking with mGlu5 allosteric modulators. Psychopharmacology. vol 237. issue 1. 2020-04-10. PMID:31446451. |
cocaine use disorder (cud) remains difficult to treat with no fda-approved medications to reduce relapse. |
2020-04-10 |
2023-08-13 |
Not clear |